Clinical Trial Update: A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

This update describes an early-phase window-of-opportunity trial of Troriluzole for recurrent IDH-wild-type glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Troriluzole (troriluzole)

Snippet

Sponsor: Ugonma Chukwueke | Conditions: Glioblastoma, Recurrent Glioblastoma | EARLY_Phase 1 | Status: RECRUITING